EdgarLookup

KESTRA MEDICAL TECHNOLOGIES, LTD. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Financials Insiders
Insider Title Type Shares Price Value Date
Umberger Traci S See Remarks Sale 10,500 $26.69 $280,245 Dec 29, 2025
Webster Brian Daniel See Remarks Sale 15,000 $26.59 $398,850 Dec 29, 2025
Moran Timothy P. Chief Business Officer Award / Grant 19,557 Dec 3, 2025
Ladone Mary Kay Award / Grant 10,909 Sep 4, 2025
Hanley Conor Award / Grant 13,120 Sep 4, 2025
Schwartz Jeffrey Lawrence Award / Grant 10,909 Sep 4, 2025
Kwo Elizabeth Award / Grant 10,909 Sep 4, 2025
COHEN RAYMOND W Award / Grant 12,994 Jul 24, 2025
Webster Brian Daniel See Remarks Award / Grant 88,235 Jul 17, 2025
Mahboob Vaseem Chief Financial Officer Award / Grant 22,059 Jul 17, 2025
Umberger Traci S See Remarks Award / Grant 29,412 Jul 17, 2025
Ford Alfred J Jr Chief Commercial Officer Award / Grant 29,412 Jul 17, 2025
Ford Alfred J Jr Chief Commercial Officer Purchase 20,000 $17.00 $340,000 Mar 7, 2025
Umberger Traci S See Remarks Purchase 13,500 $17.00 $229,500 Mar 7, 2025
COHEN RAYMOND W Award / Grant 10,909 Mar 7, 2025